Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Culture, Organoids & Tox Screening Europe 2019

3D-Culture, Organoids & Tox Screening Europe 2019



Conference Chairman

Terry Riss

Terry Riss
Global Strategic Marketing Manager Cell Health, Promega Corporation

Keynote Speakers


Peter Ertl
Professor of Lab-on-a-Chip Systems, Vienna University of Technology


Gary Gintant
Senior Research Fellow, Abbvie


David Hay
Chair of Tissue Engineering, MRC Centre for Regenerative Medicine, University of Edinburgh


James Hickman
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos


Noo Li Jeon
Professor, Seoul National University


Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)


Robert Vries
CEO, Hubrecht Organoid Technology (HUB)


Paul Vulto
Managing Director, MIMETAS

Overview

SelectBIO 3D-Culture, Organoids & Tox Screening Europe 2019 brings together researchers from around the world focusing on the emerging technologies and applications of 3D-culture and organoids, especially as they are impacting drug discovery, toxicity screening and drug development processes.

Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines (and cells derived thereof), and those responsible for developing the techniques and technologies in the organoids field. There will also be discussions on industry and regulatory developments that are shaping the future of 3D-culture and technologies for studying organoids in cancer research and beyond.

Topics to be covered include 3D-cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.

Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.

Information and Local Registration Facilities for this Conference are Also Available In:

Japanese  |  Korean  |  Chinese (Simplified)  |  Chinese (Traditional)

Agenda Topics

  • 3D-Cell Culture Based Models
  • High-Content Screening and Imaging Technologies
  • iPSC-derived Cells for Toxicity Testing and Pharmaceutical Screening
  • Organoids
  • Phenotypic and High Content Screening of 3D-Model Systems
  • Phenotypic Drug Discovery
  • Screening Technologies, Instrumentation and Reagents
  • Stem Cells in Drug Discovery and Toxicity Screening
  • Technologies in 3D-Cell Culture

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Distinguished Faculty

Jens Kelm, CEO and Co-Founder, PreComb Therapeutics AG
Nathalie Maubon, CEO/CSO, HCS Pharma
Bram Herpers, COO, OcellO B V
Murat Cirit, Director at Translational Center of Tissue Chip Technologies, Massachusetts Institute of Technology (MIT)
Daniele Zink, Principal Research Scientist and Team Leader, Institute of Bioengineering and Nanotechology, Agency for Science Technology and Research (A*STAR)
Silvia Scaglione, Professor, National Council of Research (CNR), Genoa (Italy) and Head of Laboratory of Tissue Engineering
Robert Halliwell, Professor of Neuroscience and Clinical Pharmacology, University of The Pacific
David Pamies, Researcher, University of Lausanne
Maciej Daniszewski, Researcher, University of Melbourne
Christina Fey, Researcher, Tissue Engineering and Regenerative Medicine, University hospital W├╝rzburg
Sara Previdi, Scientist, University Medical Center Leiden
Katharina Schimek, Senior Scientist and Project Manager, TissUse GmbH


Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks